By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 82.25 |
Change Today | 0.25 |
% Change | 0.31 % |
52 Week High | 109.62 |
52 Week Low | 78.84 |
Volume | 683,509 |
Shares Issued | 1,256.00m |
Market Cap | 103,307m |
Beta | 0.73 |
Strong Buy | 13 |
Buy | 6 |
Neutral | 8 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
17:07 | 25 @ 82.25 |
17:07 | 6 @ 82.25 |
17:07 | 11 @ 82.25 |
17:07 | 33 @ 82.25 |
17:07 | 60 @ 82.24 |
You are here: research